Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2008 17:37 ET | Source: MediciNova, Inc.

MediciNova Reports First Quarter 2008 Results

SAN DIEGO, May 12, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
April 07, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Clinical Results From Two-Year Phase II Clinical Trial of MN-166 in Multiple Sclerosis

SAN DIEGO, April 7, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
April 02, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova to Present Additional Clinical Data Demonstrating Potential Neuroprotection Benefits of MN-166 in Multiple Sclerosis At the 18th Meeting of the European Neurological Society

SAN DIEGO, April 2, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
March 31, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova Initiates Phase II Clinical Trial of MN-221 in Status Asthmaticus Patients

SAN DIEGO, March 31, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
March 27, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova Announces Record Date for Annual Meeting

SAN DIEGO, March 27, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on NASDAQ (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange...
March 17, 2008 17:30 ET | Source: MediciNova, Inc.

MediciNova Reports Fourth Quarter and Full Year 2007 Results

SAN DIEGO, March 17, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
February 08, 2008 04:00 ET | Source: MediciNova, Inc.

MediciNova Reports Cash, Cash Equivalents and Short-Term Marketable Securities as of December 31, 2007 (Unaudited)

SAN DIEGO, Feb. 8, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
February 01, 2008 04:00 ET | Source: MediciNova, Inc.

MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients

SAN DIEGO, Feb. 1, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
November 09, 2007 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Third Quarter 2007 Results

SAN DIEGO, Nov. 9, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
November 08, 2007 06:00 ET | Source: MediciNova, Inc.

MediciNova Announces Withdrawal of Common Stock Offering

SAN DIEGO, Nov. 8, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...